This inventor holds 1 USPTO granted patent. Top assignee: Eprov A.g.. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: The Innovations of Tom J Rabelink
Introduction
Tom J Rabelink is a notable inventor based in Utrecht, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cardiovascular and neurological disorders. His innovative approach combines the use of folic acid or a folate with tetrahydrobiopterin (BH4) to enhance the modulation of nitric oxide synthase (NOS).
Latest Patents
Rabelink holds a patent for a pharmaceutical preparation that contains at least folic acid or a folate and tetrahydrobiopterin (BH4) or derivatives thereof. This invention is aimed at treating or preventing cardiovascular or neurological disorders by modulating the activity of nitric oxide synthase (NOS). The patent highlights the potential of these compounds in improving health outcomes for patients suffering from these conditions. He has 1 patent to his name.
Career Highlights
Throughout his career, Rabelink has been associated with Eprov AG, where he has been instrumental in advancing research and development in pharmaceutical preparations. His work has garnered attention for its innovative approach to addressing complex health issues.
Collaborations
Rabelink collaborates with various professionals in the field, including his coworker Rudolf Moser. Their combined expertise contributes to the ongoing development of effective pharmaceutical solutions.
Conclusion
Tom J Rabelink's contributions to the field of pharmaceuticals demonstrate his commitment to innovation and improving health outcomes. His work continues to inspire advancements in the treatment of cardiovascular and neurological disorders.